NGD-931

N/A

Report date: 2023/05/17 08:52:00

Base Information

Drug NameNGD-931

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionDopamine receptors antagonists

TargetsDopamine receptors

Therapy Area/IndicationsPsychotic Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNeurogen Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNeurogen Corp

Active IndicationsN/A

Inactive IndicationsPsychotic Disorders

ATC CodeN/A